IB-T101

· Grit Biotechnology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IB-T101, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 1]